Dr. Chertow is an officer in the United States Public Health Service (USPHS) and an investigator at the National Institutes of Health (NIH) where he leads the Emerging Pathogens Section of the Critical Care Medicine Department at the NIH Clinical Center and the Laboratory of Immunoregulation within the National Institute of Allergy and Infectious Diseases. Dr. Chertow received his undergraduate degree in Sociology from Boston College, his medical degree from Northwestern University, and his master’s in public health from the University of California, Berkeley. He completed residency training in Internal Medicine at the University of California, San Diego and training as an Epidemic Intelligence Service Officer at the United States Centers for Disease Control and Prevention. Fellowship training in Critical Care Medicine was completed at NIH and Infectious Diseases at Johns Hopkins University. Dr. Chertow is board certified in Critical Care Medicine and Infectious Diseases and practices in a multidisciplinary intensive care unit at the NIH Clinical Center. His translational research program employs advanced animal models and natural history studies in humans to improve understanding of pathogenesis of critical illness due to severe emerging infectious diseases including Ebola virus disease and Coronavirus disease 2019. Dr. Chertow is committed to mentoring clinical and laboratory trainees pursuing careers in medicine and basic and translational research.
Daniel S. Chertow, MD, MPH